Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients.
Transpl Infect Dis
; 18(6): 904-912, 2016 Dec.
Article
em En
| MEDLINE
| ID: mdl-27639246
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Ganciclovir
/
Transplante de Rim
/
Infecções por Citomegalovirus
/
Antibioticoprofilaxia
/
Citomegalovirus
Tipo de estudo:
Diagnostic_studies
/
Guideline
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article